Theralink Technologies, Inc. (THER)
OTCMKTS
· Delayed Price · Currency is USD
0.00
0.00 (0.00%)
At close: Dec 30, 2024
Theralink Technologies Revenue
Theralink Technologies had revenue of $83.95K in the quarter ending December 31, 2023, with 51.82% growth. This brings the company's revenue in the last twelve months to $635.45K, up 16.76% year-over-year. In the fiscal year ending September 30, 2023, Theralink Technologies had annual revenue of $606.80K with 6.85% growth.
Revenue (ttm)
635.45K
Revenue Growth
+16.76%
P/S Ratio
0.01
Revenue / Employee
39.72K
Employees
16
Market Cap
6.15K
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
Veradigm | 1.53B |
SS Innovations International | 16.04M |
Elite Pharmaceuticals | 71.17M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
BioStem Technologies | 210.49M |
Silence Therapeutics | 21.77M |
Theralink Technologies News
- 1 year ago - Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates - GlobeNewsWire
- 1 year ago - Theralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4 - GlobeNewsWire
- 1 year ago - Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute's Molecular Tumor Board - GlobeNewsWire
- 1 year ago - Theralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023 - GlobeNewsWire
- 1 year ago - Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer - GlobeNewsWire
- 1 year ago - THERALINK INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Theralink Technologies, Inc. - THER - Business Wire
- 1 year ago - Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University - PRNewsWire
- 2 years ago - Theralink® Technologies Begins Receiving Payments from Third Party Payors for its Advanced Breast Cancer Assay, Achieving Key Milestone - PRNewsWire